Vascular Diseases D014652

Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases

Description

Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.   MeSH

Hierarchy View

Subtype Terms (44)

Aneurysm
29 drugs (27 approved, 2 experimental)

Angiodysplasia
4 approved drugs

Angioedema
23 drugs (19 approved, 4 experimental)

Angiomatosis
3 approved drugs

Aortic Diseases
30 drugs (26 approved, 4 experimental)

Arterial Occlusive Diseases
95 drugs (71 approved, 24 experimental)

Arteriovenous Malformations
10 drugs (8 approved, 2 experimental)

Capillary Leak Syndrome
2 approved drugs

Cerebrovascular Disorders
62 drugs (44 approved, 18 experimental)

Colitis, Ischemic
 

Compartment Syndromes
 

Diabetic Angiopathies
8 drugs (6 approved, 2 experimental)

Embolism and Thrombosis
11 drugs (10 approved, 1 experimental)

Hand-Arm Vibration Syndrome
 

Hemorrhoids
53 drugs (28 approved, 25 experimental)

Hemostatic Disorders
3 drugs (1 approved, 2 experimental)

Hepatic Veno-Occlusive Disease
3 approved drugs

Hyperemia
8 drugs (6 approved, 2 experimental)

Hypertension
578 drugs (272 approved, 306 experimental)

Hypotension
121 drugs (90 approved, 31 experimental)

Mesenteric Ischemia
1 approved drug

Myocardial Ischemia
181 drugs (121 approved, 60 experimental)

Optic Neuropathy, Ischemic
24 drugs (18 approved, 6 experimental)

Peliosis Hepatis
 

Peripheral Vascular Diseases
74 drugs (35 approved, 39 experimental)

Prehypertension
47 drugs (29 approved, 18 experimental)

Pulmonary Veno-Occlusive Disease
3 approved drugs

Reperfusion Injury
79 drugs (62 approved, 17 experimental)

Retinal Vein Occlusion
45 drugs (28 approved, 17 experimental)

Scimitar Syndrome
 

Spinal Cord Vascular Diseases
 

Splenic Infarction
 

Stenosis, Pulmonary Vein
1 approved drug

Superior Vena Cava Syndrome
 

Telangiectasis
8 drugs (4 approved, 4 experimental)

Thoracic Outlet Syndrome
2 approved drugs

Varicocele
4 approved drugs

Varicose Veins
21 drugs (12 approved, 9 experimental)

Vascular Fistula
 

Vascular Neoplasms
1 approved drug

Vascular System Injuries
6 drugs (1 approved, 5 experimental)

Vasculitis
38 drugs (28 approved, 10 experimental)

Vasoplegia
12 drugs (11 approved, 1 experimental)

Venous Insufficiency
19 drugs (4 approved, 15 experimental)



Organization Involved with Phase 4 Indications (78)

Organization Involved with Phase 3 Indications (81)

Organization Involved with Phase 2 Indications (74)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.